Regeneron Research Site

Bethesda, Maryland 20817

We've found

2 trials

at this facility

A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Bethesda, MD

REGN2810 (Anti-PD-1 Antibody), Ipilimumab (Anti-CTLA-4 Antibody), and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Bethesda, MD

Use our guide to learn which trials are right for you!